www.fdanews.com/articles/176191-fda-approves-biotroniks-biomonitor-2-insertable-cardiac-monitor
FDA Approves Biotronik’s BioMonitor 2 Insertable Cardiac Monitor
April 13, 2016
Biotronik has scored FDA approval for its BioMonitor 2 insertable cardiac remote monitor with ProMRI technology.
The device is inserted subcutaneously under anesthesia and is designed to detect and diagnose atrial fibrillation, ventricular tachycardia and fibrillation, and syncope.
BioMonitor 2 holds more than 60 minutes of electrocardiogram recording time and intelligent memory management. — Anisa Jibrell